GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Jiang Xi Sanxin Medtec Co Ltd (SZSE:300453) » Definitions » Beneish M-Score

Jiang Xinxin Medtec Co (SZSE:300453) Beneish M-Score : -3.04 (As of Mar. 31, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Jiang Xinxin Medtec Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -3.04 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Jiang Xinxin Medtec Co's Beneish M-Score or its related term are showing as below:

SZSE:300453' s Beneish M-Score Range Over the Past 10 Years
Min: -3.55   Med: -2.91   Max: -2.39
Current: -3.04

During the past 13 years, the highest Beneish M-Score of Jiang Xinxin Medtec Co was -2.39. The lowest was -3.55. And the median was -2.91.


Jiang Xinxin Medtec Co Beneish M-Score Historical Data

The historical data trend for Jiang Xinxin Medtec Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiang Xinxin Medtec Co Beneish M-Score Chart

Jiang Xinxin Medtec Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.97 -3.11 -2.98 -2.71 -3.04

Jiang Xinxin Medtec Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.71 -3.00 -2.90 -3.14 -3.04

Competitive Comparison of Jiang Xinxin Medtec Co's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Jiang Xinxin Medtec Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Jiang Xinxin Medtec Co's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Jiang Xinxin Medtec Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Jiang Xinxin Medtec Co's Beneish M-Score falls into.


;
;

Jiang Xinxin Medtec Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Jiang Xinxin Medtec Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.7587+0.528 * 0.9875+0.404 * 0.6641+0.892 * 1.1541+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9024+4.679 * -0.072966-0.327 * 1.0388
=-3.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec24) TTM:Last Year (Dec23) TTM:
Total Receivables was ¥91 Mil.
Revenue was 418.113 + 395.872 + 355.294 + 331.159 = ¥1,500 Mil.
Gross Profit was 150.951 + 138.255 + 125.651 + 115.243 = ¥530 Mil.
Total Current Assets was ¥824 Mil.
Total Assets was ¥2,223 Mil.
Property, Plant and Equipment(Net PPE) was ¥1,088 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥77 Mil.
Total Current Liabilities was ¥578 Mil.
Long-Term Debt & Capital Lease Obligation was ¥158 Mil.
Net Income was 59.489 + 61.667 + 52.629 + 53.619 = ¥227 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 65.995 + 187.426 + 100.751 + 35.415 = ¥390 Mil.
Total Receivables was ¥104 Mil.
Revenue was 370.1 + 348.215 + 308.827 + 272.919 = ¥1,300 Mil.
Gross Profit was 133.656 + 124.434 + 104.699 + 90.772 = ¥454 Mil.
Total Current Assets was ¥692 Mil.
Total Assets was ¥2,031 Mil.
Property, Plant and Equipment(Net PPE) was ¥912 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥74 Mil.
Total Current Liabilities was ¥565 Mil.
Long-Term Debt & Capital Lease Obligation was ¥82 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(91.171 / 1500.438) / (104.121 / 1300.061)
=0.060763 / 0.080089
=0.7587

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(453.561 / 1300.061) / (530.1 / 1500.438)
=0.348877 / 0.353297
=0.9875

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (823.955 + 1088.251) / 2222.71) / (1 - (691.76 + 911.842) / 2030.808)
=0.139696 / 0.210363
=0.6641

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1500.438 / 1300.061
=1.1541

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 911.842)) / (0 / (0 + 1088.251))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(76.834 / 1500.438) / (73.772 / 1300.061)
=0.051208 / 0.056745
=0.9024

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((157.873 + 577.596) / 2222.71) / ((81.93 + 564.953) / 2030.808)
=0.330888 / 0.318535
=1.0388

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(227.404 - 0 - 389.587) / 2222.71
=-0.072966

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Jiang Xinxin Medtec Co has a M-score of -3.04 suggests that the company is unlikely to be a manipulator.


Jiang Xinxin Medtec Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Jiang Xinxin Medtec Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Jiang Xinxin Medtec Co Business Description

Traded in Other Exchanges
N/A
Address
No. 999, Fushan Avenue, Xiaolan Economic Development Zone, Nanchang County, Jiangxi Province, Nanchang, CHN, 330200
Jiang Xi Sanxin Medtec Co Ltd is engaged in researching and developing, manufacturing and marketing of medical devices. Its products include four series: blood purification, indwelling catheters, injections, infusion and blood transfusion. Blood purification products are used in clinical dialysis treatment for uremic patients. Indwelling catheter products represented by venous indwelling needles, positive pressure indwelling needles, central venous catheters. Injectable products mainly include self-destructing syringes, retracting self-destructing syringes, conjoined syringes.
Executives
Zhang Lin Supervisors
Le Zhen Rong Executives
Mao Zhi Ping Directors, executives
Yu Zhen Zhu Supervisors
Peng Yi Xing Director
Liu Ming Securities Affairs Representative
Wan Xiao Ping Director
Wang Qin Hua Supervisors
Xiong Yan Supervisors

Jiang Xinxin Medtec Co Headlines

No Headlines